Passwort vergessen?
Werden Sie kostenlos Mitglied
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Dynamische Kurse 


verzögerte Kurse. Verzögert Nyse - 02.08. 22:10:00
246.6 USD   +1.27%
29.06.++ Analysen des Tages von Dow Jones Newswires (29.06.2021) +++
24.06.MÄRKTE USA/Wall Street mit Rekorden - Politik schiebt an
24.06.MÄRKTE USA/Wall Street in Rekordlaune
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-NewsMarketScreener Analysen
Nachrichten in anderen Sprachen über ELI LILLY AND COMPANY
08:18EN DIRECT DES MARCHES : Société Générale, Stellantis, Sanofi, TotalEnergies, Ten..
07:14BÖRSE PARIS : Les champions insoupçonnés de l'année
02.08.Virus woes, slowing economic growth weigh on Wall Street
30.07.ELI LILLY AND : FCA Upholds Award Of Compound Interest In Cefaclor Damages Appea..
29.07.ELI LILLY AND : Lilly releases donanemab data that demonstrated relationship bet..
29.07.ELI LILLY AND : Incyte Get Expanded Emergency Use Approval for Baricitinib as Mo..
29.07.ELI LILLY : EUA élargie pour le baricitinib dans la Covid-19
29.07.Eli Lilly, Kumquat Biosciences Form Cancer Collaboration
29.07.ELI LILLY AND : FDA broadens existing emergency use of Lilly and Incyte's barici..
29.07.ELI LILLY AND : Unit, Kumquat Biosciences to Develop Molecules for Tumor Immunit..
29.07.Lilly, Incyte Get Emergency Use Authorization for Covid-19 Treatment as Monot..
29.07.ELI LILLY AND : Unit, Kumquat Biosciences to Develop Molecules to Invoke Tumor I..
29.07.ELI LILLY AND : Lilly and Kumquat Biosciences Announce Collaboration to Discover..
24.07.ELI LILLY AND : (LLY) sees Significant Insider Selling Continuing
23.07.A Guiding Light For The Research Safe Harbor And "Research Tools"?
23.07.ELI LILLY AND : Significant Insider Selling Continues at Eli Lilly (LLY)
22.07.INSIDER TRENDS : Insider 90-Day Selling Trend Prolonged at Eli Lilly
22.07.ELI LILLY AND : Lilly Confirms Date and Conference Call for Second-Quarter 2021 ..
21.07.INSIDER TRENDS : Selling By Insiders Continues at Eli Lilly
19.07.TALKSPACE : Hires Jennifer Fulk as CFO
17.07.ELI LILLY AND : Insider Selling in Eli Lilly (LLY) Shares Continues
16.07.Health Care Climbs On Defensive Bias -- Health Care Roundup
16.07.ELI LILLY AND : Incyte Say FDA May Miss Target Action Data for Baricitinib
16.07.ELI LILLY AND : Incyte Say FDA to Miss PDUFA Target Action Data for Baricitinib
16.07.ELI LILLY AND : Lilly and Incyte provide update on supplemental New Drug Applica..
15.07.BIOGEN : Slumps After Cleveland Clinic, Mount Sinai Say They Won't Use Controver..
15.07.INSIDER TRENDS : Insider Adds to Selling Trend at Eli Lilly
15.07.ELI LILLY AND : Banner Alzheimer's Institute Team Up in Late-Stage Trial of Dona..
15.07.ELI LILLY AND : Lilly and Banner Alzheimer's Institute collaborate on planned Ph..
15.07.Lilly and Banner Alzheimer's Institute Collaborate on Planned Phase 3 Prevent..
15.07.Lilly and Banner Alzheimer's Institute Collaborate on Phase 3 Trial of Donane..
14.07.ELI LILLY AND : Acquires Protomer Technologies For Over $1 Billion
14.07.ELI LILLY : acquisition de Protomer Technologies
14.07.ELI LILLY AND : Acquires Protomer Technologies
14.07.ELI LILLY AND : Lilly Announces Acquisition of Protomer Technologies
14.07.Lilly Buys Protomer Technologies in Deal Worth Up to $1 Billion
14.07.GSK-Vir Biotechnology's COVID-19 Antibody Wins Distribution Nod in Italy
14.07.ELI LILLY AND : Insider Selling in Eli Lilly (LLY) Shares Continues
14.07.Eli Lilly and Company acquired remaining 86% stake in Protomer Technologies I..
13.07.INSIDER TRENDS : Insider Sales Add to 90-Day Trend at Eli Lilly
12.07.INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Eli Lilly
09.07.President Biden's Competition Order to Crack Down on Antitrust Practices by B..
09.07.ELI LILLY : résultats encourageants pour le mirikizumab
09.07.ELI LILLY AND : Mirikizumab Up-Regulates Genes Associated with Mucosal Healing i..
09.07.ELI LILLY AND : Says New Study Shows Mirikizumab Prompts Mucosal Healing in Ulce..
09.07.Eli Lilly and Company Announces New Phase 2 Data Showing That Gene Expression..
09.07.ELI LILLY AND : Significant Insider Selling in Shares of Eli Lilly (LLY) Continu..
08.07.SECTOR UPDATE : Health Care Stocks Trade Lower Premarket Thursday
08.07.ELI LILLY AND : Verge Genomics Enter Into Three-Year Agreement to Co-Develop Pot..
08.07.Verge Genomics Announces Three-Year Collaboration with Eli Lilly and Company ..
08.07.ELI LILLY AND : Insider Selling in Eli Lilly (LLY) Shares Continues
07.07.INSIDER TRENDS : Eli Lilly Insider Continues 90-Day Selling Trend
06.07.INSIDER TRENDS : Selling By Insiders Lingers at Eli Lilly
06.07.ELI LILLY AND : Says Phase 3 Trial of Jardiance Meets Endpoint of Reducing Heart..
06.07.ELI LILLY : résultats positifs dans l'insuffisance cardiaque
06.07.ELI LILLY AND : Breakthrough results for Jardiance® (empagliflozin) confirm EMPE..
06.07.Boehringer Ingelheim and Eli Lilly and Company Confirms Results for Jardiance..
06.07.ELI LILLY, BOEHRINGER INGELHEIM : Jardiance Trial Meets Primary Endpoint
06.07.MiNA Therapeutics Limited announced that it expects to receive $15 million in..
01.07.ELI LILLY AND : Lilly Diabetes Update at ADA Presentation
30.06.ELI LILLY : déclare le dividende du 3e trimestre
30.06.EU Adds Eli Lilly's Antibodies, Four Other Drugs in COVID-19 Therapeutics Por..
30.06.ELI LILLY AND : Settles Sexual Discrimination Lawsuit From Former Lobbyist
29.06.ELI LILLY AND : Retains Quarterly Dividend of $0.85 a Share, Payable Sept. 10 to..
29.06.ELI LILLY AND : Lilly Declares Third-Quarter 2021 Dividend
29.06.Eli Lilly and Company Declares Dividend for the Third Quarter of 2021, Payabl..
29.06.WALMART : Launches Private Brand Analog Insulin; Eli Lilly Welcomes Move
29.06.EU picks antibody treatments, arthritis drug as preferred COVID-19 therapies
29.06.ELI LILLY AND : Insider Sale at Eli Lilly (LLY) Continues Selling Trend
28.06.LIGAND PHARMACEUTICALS INCORPORATED : Sermonix Completes Enrollment in Phase 2 C..
28.06.Lilly Says Drug Reduces A1C, Body-Weight Levels in Adults With Type 2 Diabete..
25.06.ELI LILLY AND : Study Shows Tirzepatide Superior to Semaglutide in Lowering Bloo..
25.06.INSIDER TRENDS : Insider 90-Day Selling Trend Extended at Eli Lilly
25.06.Eli Lilly and Company's SURPASS-2 Results Publishes in The New England Journa..
25.06.Lilly Sees Positive Results from Trial for Tirzepatide
1  2  3  4  5  6  7  8  9  10Weiter
Anstehende Termine für ELI LILLY AND COMPANY